Short TEG: cessation of clopidogrel following insertion of drug-eluting coronary stents
Completed
- Conditions
- Topic: CardiovascularPercutaneous coronary interventionSubtopic: Cardiovascular (all Subtopics)Circulatory SystemDisease: Cardiovascular
- Registration Number
- ISRCTN51917813
- Lead Sponsor
- Southampton University Hospitals NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. Aged greater than 18 years, either sex
2. Signed written informed consent
3. Prior percutaneous coronary intervention (PCI) with drugeluting stent implantation and due to stop clopidogrel 12 months after PCI
4. On maintenance dose aspirin 75 mg and clopidogrel 75 mg daily
5. 30 diabetics and 30 nondiabetics
Exclusion Criteria
1. Aged greater than 85 years
2. On regular nonsteroidal antiinflammatory medication or steroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clopidogrel is routinely used for 12 months after drugeluting stent implantation
- Secondary Outcome Measures
Name Time Method Any differences in inflammatory markers, measured at 12 months